These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 22273137)
21. Simultaneous detection of antibody binding and cytotoxicity in flow cytometry crossmatch for renal transplantation. Won DI; Jeong HD; Kim YL; Suh JS Cytometry B Clin Cytom; 2006 Mar; 70(2):82-90. PubMed ID: 16470535 [TBL] [Abstract][Full Text] [Related]
22. Comparative analysis of Luminex-based donor-specific antibody mean fluorescence intensity values with complement-dependent cytotoxicity & flow crossmatch results in live donor renal transplantation. Baranwal AK; Bhat DK; Goswami S; Agarwal SK; Kaur G; Kaur J; Mehra N Indian J Med Res; 2017 Feb; 145(2):222-228. PubMed ID: 28639599 [TBL] [Abstract][Full Text] [Related]
23. Influence of donor specific HLA antibodies detected by Luminex in kidney graft survival: a multivariate analysis. Caro-Oleas JL; González-Escribano MF; Gentil-Govantes MA; Acevedo MJ; González-Roncero FM; Bernal-Blanco G; Núñez-Roldán A Hum Immunol; 2013 May; 74(5):545-9. PubMed ID: 23376459 [TBL] [Abstract][Full Text] [Related]
24. Sensitization and sensitivity: defining the unsensitized patient. Gebel HM; Bray RA Transplantation; 2000 Apr; 69(7):1370-4. PubMed ID: 10798756 [TBL] [Abstract][Full Text] [Related]
25. No advantage of flow cytometry crossmatch over complement-dependent cytotoxicity in immunologically well-documented renal allograft recipients. Christiaans MH; Overhof R; ten Haaft A; Nieman F; van Hooff JP; van den Berg-Loonen EM Transplantation; 1996 Nov; 62(9):1341-7. PubMed ID: 8932282 [TBL] [Abstract][Full Text] [Related]
26. Improved graft survival in highly sensitized patients undergoing renal transplantation after the introduction of a clinically validated flow cytometry crossmatch. Limaye S; O'Kelly P; Harmon G; O'Neill D; Dorman AM; Walshe J; Donohoe J; Little D; Conlon PJ; Keogan MT Transplantation; 2009 Apr; 87(7):1052-6. PubMed ID: 19352127 [TBL] [Abstract][Full Text] [Related]
27. Virtual crossmatch by identification of donor-specific anti-human leukocyte antigen antibodies by solid-phase immunoassay: a 30-month analysis in living donor kidney transplantation. Morris GP; Phelan DL; Jendrisak MD; Mohanakumar T Hum Immunol; 2010 Mar; 71(3):268-73. PubMed ID: 20074605 [TBL] [Abstract][Full Text] [Related]
28. Practical value of identifying antibodies to cryptic HLA epitopes in cardiac transplantation. Oaks M; Michel K; Sulemanjee NZ; Thohan V; Downey FX J Heart Lung Transplant; 2014 Jul; 33(7):713-20. PubMed ID: 24661683 [TBL] [Abstract][Full Text] [Related]
29. Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts. Lawrence C; Willicombe M; Brookes PA; Santos-Nunez E; Bajaj R; Cook T; Roufosse C; Taube D; Warrens AN Transplantation; 2013 Jan; 95(2):341-6. PubMed ID: 23197178 [TBL] [Abstract][Full Text] [Related]
32. Antibody monitoring system to support the single-antigen Luminex assay in donor-specific antibody detection. Hwang HS; Sun IO; Yoon HE; Choi BS; Oh EJ; Kim JI; Moon IS; Kim YS; Yang CW Hum Immunol; 2012 Apr; 73(4):370-5. PubMed ID: 22342452 [TBL] [Abstract][Full Text] [Related]
34. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation. Lee PC; Ozawa M; Hung CJ; Lin YJ; Chang SS; Chou TC Transplant Proc; 2009; 41(1):95-8. PubMed ID: 19249487 [TBL] [Abstract][Full Text] [Related]
35. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients. Meng HL; Jin XB; Li XT; Wang HW; Lü JJ Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748 [TBL] [Abstract][Full Text] [Related]
36. Renal transplantation in sensitized recipients with positive luminex and negative CDC (complement-dependent cytotoxicity) crossmatches. Huh KH; Kim MS; Kim HJ; Joo DJ; Kim BS; Ju MK; Kim SI; Kim YS Transpl Int; 2012 Nov; 25(11):1131-7. PubMed ID: 22897830 [TBL] [Abstract][Full Text] [Related]
37. Preformed antibodies detected by cytotoxic assay or multibead array decrease liver allograft survival: role of human leukocyte antigen compatibility. Castillo-Rama M; Castro MJ; Bernardo I; Meneu-Diaz JC; Elola-Olaso AM; Calleja-Antolin SM; Romo E; Morales P; Moreno E; Paz-Artal E Liver Transpl; 2008 Apr; 14(4):554-62. PubMed ID: 18383092 [TBL] [Abstract][Full Text] [Related]
38. Detection of donor-specific antibodies using HLA-coated microspheres: another tool for kidney transplant risk stratification. Gibney EM; Cagle LR; Freed B; Warnell SE; Chan L; Wiseman AC Nephrol Dial Transplant; 2006 Sep; 21(9):2625-9. PubMed ID: 16644776 [TBL] [Abstract][Full Text] [Related]
39. Reassessment of T Lymphocytes Crossmatches Results Prediction With Luminex Class I Single Antigen Flow Beads Assay. Visentin J; Bachelet T; Borg C; Franchini N; Nong T; Lee JH; Couzi L; Merville P; Guidicelli G; Taupin JL Transplantation; 2017 Mar; 101(3):624-630. PubMed ID: 27336398 [TBL] [Abstract][Full Text] [Related]
40. Sensitivity, specificity and clinical relevance of different cross-matching assays in deceased-donor renal transplantation. Ho EK; Vasilescu ER; Colovai AI; Stokes MB; Hallar M; Markowitz GS; D'Agati VD; Cohen DJ; Ratner LE; Suciu-Foca N Transpl Immunol; 2008 Nov; 20(1-2):61-7. PubMed ID: 18929659 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]